PerkinElmer Inc. Fourth Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component PerkinElmer, Inc. (NYSE:PKI) will unveil its latest earnings on Thursday, February 2, 2012. PerkinElmer provides technology, services, and solutions to the environmental monitoring, diagnostics, academic research, and safety security markets.

PerkinElmer, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 51 cents per share, a rise of 15.9% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 52 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 51 cents during the last month. Analysts are projecting profit to rise by 26.3% versus last year to $1.68.

Past Earnings Performance: Last quarter, the company beat estimates by 2 cents, coming in at profit of 41 cents a share versus the estimate of net income of 39 cents a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

Wall St. Revenue Expectations: Analysts are projecting a rise of 14.3% in revenue from the year-earlier quarter to $537.1 million.

Analyst Ratings: Analysts are bullish on PerkinElmer as four analysts rate it as a buy, none rate it as a sell and four rate it as a hold.

A Look Back: In the third quarter, profit rose more than twofold to $35.3 million (31 cents a share) from $13.4 million (11 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 8.3% to $453.7 million from $419.1 million.

Key Stats:

A year-over-year revenue increase in the third quarter snapped a streak of three consecutive quarters of revenue declines. Revenue fell 3.7% in the second quarter, 3.7% in the first quarter and 7.7% in the fourth quarter of the last fiscal year.

The increase in profit in the third quarter broke a streak of two consecutive quarters of year-over-year profit decreases. The figure dropped 50.5% in the second quarter and 3.6% in the first quarter.

Competitors to Watch: Thermo Fisher Scientific Inc. (NYSE:TMO), Waters Corporation (NYSE:WAT), Beckman Coulter, Inc. (NYSE:BEC), Bruker Corporation (NASDAQ:BRKR), Harvard Bioscience, Inc. (NASDAQ:HBIO), Agilent Technologies Inc. (NYSE:A), Caliper Life Sciences Inc. (NASDAQ:CALP), Becton, Dickinson and Co. (NYSE:BDX), Bio-Rad Laboratories, Inc. (NYSE:BIO), and Sequenom, Inc. (NASDAQ:SQNM).

Stock Price Performance: During November 29, 2011 to January 27, 2012, the stock price had risen $6.15 (34.5%) from $17.84 to $23.99. The stock price saw one of its best stretches over the last year between January 4, 2012 and January 12, 2012 when shares rose for seven-straight days, rising 9.8% (+$1.99) over that span. It saw one of its worst periods between September 14, 2011 and September 22, 2011 when shares fell for seven-straight days, falling 10.7% (-$2.25) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?